Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Dierks

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
JCO Precision Oncology|September 11, 2020
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center ExperienceRouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch, et al.
The Journal of Clinical Investigation|April 28, 2020
Loss of the Fanconi anemia-associated protein NIPA causes bone marrow failureStefanie Kreutmair, Miriam Erlacher, Geoffroy Andrieux, et al.
Cell|January 14, 2017
DNA Damage Signaling Instructs Polyploid Macrophage Fate in GranulomasLaura Herrtwich, Indrajit Nanda, Konstantinos Evangelou, et al.
Annals of Hematology|July 8, 2025
VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AMLLydia Kretschmer, Leo Ruhnke, Christoph Schliemann, et al.
Cancers|April 3, 2021
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center AnalysisRouven Hoefflin, Adriana Lazarou, Maria Elena Hess, et al.
Blood|May 1, 2020
Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease driversAlexandre Fagnan, Frederik Otzen Bagger, Maria-Riera Piqué-Borràs, et al.
Science Translational Medicine|February 23, 2018
Oncogenic JAK2<sup>V617F</sup> causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasmsAlessandro Prestipino, Alica J Emhardt, Konrad Aumann, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
JCO Precision Oncology|September 11, 2020
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center ExperienceRouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch, et al.
The Journal of Clinical Investigation|April 28, 2020
Loss of the Fanconi anemia-associated protein NIPA causes bone marrow failureStefanie Kreutmair, Miriam Erlacher, Geoffroy Andrieux, et al.
Cell|January 14, 2017
DNA Damage Signaling Instructs Polyploid Macrophage Fate in GranulomasLaura Herrtwich, Indrajit Nanda, Konstantinos Evangelou, et al.
Annals of Hematology|July 8, 2025
VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AMLLydia Kretschmer, Leo Ruhnke, Christoph Schliemann, et al.
Cancers|April 3, 2021
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center AnalysisRouven Hoefflin, Adriana Lazarou, Maria Elena Hess, et al.
Blood|May 1, 2020
Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease driversAlexandre Fagnan, Frederik Otzen Bagger, Maria-Riera Piqué-Borràs, et al.
Science Translational Medicine|February 23, 2018
Oncogenic JAK2<sup>V617F</sup> causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasmsAlessandro Prestipino, Alica J Emhardt, Konrad Aumann, et al.
Pageof 4